ArticleArchives of toxicology2026
Cheminformatics-based read-across prioritization of food additives with obesogenic potential and PPARγ agonist activity.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Food additives are widely used in processed foods, yet many remain insufficiently evaluated for potential metabolic-disrupting effects. In this study, we developed a cheminformatics-based read-across approach integrating curated food additive inventories with Tox21 high-throughput screening (HTS) data to prioritize food additives with potential obesogenic activity. We integrated 7917 compounds from the Tox21 dataset with 3185 compounds from curated food additive inventories, followed by rigorous data curation to yield a dataset comprising 10,077 compounds. Dimensionality reduction and clustering analyses identified 428 structurally defined clusters. Enrichment analysis of Tox21 assay endpoints identified five clusters significantly associated with peroxisome proliferator-activated receptor γ (PPARγ) agonist activity. From these PPARγ activity-enriched clusters, eight food additives not previously evaluated in Tox21 were prioritized for experimental validation and assessed in an adipogenic differentiation model of human bone marrow-derived mesenchymal stem cells (hBM-MSCs). Among them, benzyl disulfide (BD), hesperetin (HSP), and syringaldehyde (SD) significantly enhanced adiponectin biosynthesis and lipid accumulation. Pharmacological profiling further demonstrated that BD and HSP directly bound to PPARγ and induced coactivator recruitment. Collectively, these findings support the use of integrated cheminformatics read-across analysis and targeted in vitro testing for hazard identification and prioritization of food additives with potential obesogenic activity. The results provide a basis for further mechanistic and exposure-informed assessment of the prioritized candidates.
Indexed as
Identifiers
42919951What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.